Beeler D, Rosenberg R, Jordan R
J Biol Chem. 1979 Apr 25;254(8):2902-13.
Preparations of low molecular weight porcine heparin with an average specific anticoagulant activity of 94 units/mg were fractionated into "active" and "relatively inactive" forms of the mucopolysaccharide of approximately 6000 daltons each. The active fraction was further subdivided into various species with descending but significant affinities for the protease inhibitor as well as decreasing but substantial anticoagulatn potencies. "Highly active" heparin (approximately 8% of the low molecular weight pool) possesses a specific anticoagulant activity of 350 +/- 10 units/mg. The relatively inactive fraction (67% of the low molecular weight pool) exhibits a specific anticoagulant activity of 4 +/- 1 units/mg. The binding of highly active heparin to antithrombin is accurately described by a single-site binding model with a KHep-ATDISS of approximately 1 X 10(-7) M. Variations in this binding parameter secondary to changes in environmental variables indicate that charge-charge interactions as well as an increase in entropy are critical to the formation of the highly active heparin-antithrombin complex. The interaction of relatively inactive heparin with the protease inhibitor is characterized by an apparent KHep-ATDISS of 1 X 10(-4) M. In large measure, this is due to small amounts of residual active mucopolysaccharide (0.5%). The ability of the highly active heparin to accelerate the thrombin-antithrombin interaction was also examined. We were able to demonstrate that the mucopolysaccharide acts as a catalyst in this process and is able to initiate multiple rounds of enzyme-inhibitor complex formation. The rate of enzyme neutralization is increased to a maximum of 2300-fold as the concentration of heparin is raised until the inhibitor is saturated with mucopolysaccharide. Further increases in heparin concentration result in a reduction in the speed of enzyme neutralization. This appears to be due to the formation of thrombin-heparin complexes. A mathematical model is given which provides a relationship between the initial velocity of enzyme neutralization and reactant concentrations.
平均比抗凝活性为94单位/毫克的低分子量猪肝素制剂被分离成分子量约为6000道尔顿的粘多糖的“活性”和“相对无活性”形式。活性部分进一步细分为对蛋白酶抑制剂具有递减但显著亲和力以及抗凝效力递减但仍相当可观的各种组分。“高活性”肝素(约占低分子量组分的8%)具有350±10单位/毫克的比抗凝活性。相对无活性的部分(占低分子量组分的67%)表现出4±1单位/毫克的比抗凝活性。高活性肝素与抗凝血酶的结合可用单点结合模型准确描述,其肝素-抗凝血酶解离常数(KHep-ATDISS)约为1×10⁻⁷M。环境变量变化引起的该结合参数的变化表明,电荷-电荷相互作用以及熵的增加对于高活性肝素-抗凝血酶复合物的形成至关重要。相对无活性肝素与蛋白酶抑制剂的相互作用的特征是表观肝素-抗凝血酶解离常数为1×10⁻⁴M。很大程度上,这是由于存在少量残留的活性粘多糖(0.5%)。还研究了高活性肝素加速凝血酶-抗凝血酶相互作用的能力。我们能够证明该粘多糖在此过程中起催化剂作用,并且能够引发多轮酶-抑制剂复合物的形成。随着肝素浓度升高,酶中和速率增加至最大2300倍,直至抑制剂被粘多糖饱和。肝素浓度进一步增加导致酶中和速度降低。这似乎是由于凝血酶-肝素复合物的形成。给出了一个数学模型,该模型提供了酶中和初始速度与反应物浓度之间的关系。